SLNO, Soleno Therapeutics, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for SLNO

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask SLNO by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(SCPH) scPharmaceuticals, Inc
(TSRI) TSR, Inc


Latest YouTube Video:



CEO:Dr. Anish Bhatnagar M.D.

Headquarter: 100 Marine Parkway, Suite 400, Redwood City, CA, United States, 94065

Industry: Biotechnology,   Investment Track: Biotech - Neuroendocrine,   Employees: 182

Business Summary

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.